iStent infinite Trabecular Micro-Bypass System Model iS3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $395.92 | 3 | 3 |
| 2023 | $329,390 | 744 | 619 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $165,421 | 16 | 50.2% |
| Consulting Fee | $92,613 | 22 | 28.1% |
| Food and Beverage | $50,963 | 701 | 15.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,332 | 2 | 5.6% |
| Travel and Lodging | $2,458 | 6 | 0.7% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Prospective, Randomized, Controlled, Comparative Multicenter Clinical Studyof Glaukos Trabecular Micro-Bypass System Model iS3 Infinite vs. Hydrus in Adult Subjects With Primary Open-Angle Glaucoma (POAG) | Glaukos Corporation | $128,111 | 0 |
| A PROSPECTIVE | Glaukos Corporation | $37,310 | 0 |
Top Doctors Receiving Payments for iStent infinite Trabecular Micro-Bypass System Model iS3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Cleveland, OH | $183,421 | 17 |
| , MD | Glaucoma Specialist | Salt Lake City, UT | $35,438 | 3 |
| , MD | Ophthalmology | Petaluma, CA | $14,000 | 1 |
| , MD,PHD | Ophthalmology | Pasadena, CA | $11,122 | 4 |
| Inder Singh | Ophthalmology | Racine, WI | $8,717 | 2 |
| , M.D | Ophthalmology | El Paso, TX | $5,605 | 4 |
| , M.D | Ophthalmology | New York, NY | $3,750 | 1 |
| , M.D | Ophthalmology | Dallas, TX | $2,550 | 1 |
| , MD | Ophthalmology | Jersey City, NJ | $2,307 | 3 |
| , M.D | Ophthalmology | Alexandria, LA | $1,950 | 2 |
| , M.D | Cornea and External Diseases Specialist | Plymouth Meeting, PA | $1,925 | 1 |
| , MD | Ophthalmology | Jenkintown, PA | $1,712 | 2 |
| , M.D | Ophthalmology | Freehold, NJ | $1,650 | 1 |
| , MD | Glaucoma Specialist | New York, NY | $1,400 | 1 |
| , MD | Ophthalmology | Wyomissing, PA | $1,250 | 2 |
| , M.D | Ophthalmology | Cape Coral, FL | $1,154 | 5 |
| , M.D | Ophthalmology | New York, NY | $750.00 | 1 |
| , M.D | Ophthalmology | Indianapolis, IN | $679.17 | 5 |
| , MD | Ophthalmology | Beverly Hills, CA | $531.61 | 3 |
| , M.D | Ophthalmology | Beverly Hills, CA | $490.05 | 3 |
| , OD | Ophthalmology | Los Angeles, CA | $490.04 | 3 |
| , M.D | Glaucoma Specialist | Indianapolis, IN | $454.88 | 4 |
| , M.D | Ophthalmology | Minnetonka, MN | $425.00 | 1 |
| , M.D | Ophthalmology | Coeur D Alene, ID | $358.30 | 4 |
| , OD | Optometrist | Indianapolis, IN | $334.07 | 2 |
Manufacturing Companies
- Glaukos Corporation $329,786
Product Information
- Type Device
- Total Payments $329,786
- Total Doctors 621
- Transactions 747
About iStent infinite Trabecular Micro-Bypass System Model iS3
iStent infinite Trabecular Micro-Bypass System Model iS3 is a device associated with $329,786 in payments to 621 healthcare providers, recorded across 747 transactions in the CMS Open Payments database. The primary manufacturer is Glaukos Corporation.
Payment data is available from 2023 to 2024. In 2024, $395.92 was paid across 3 transactions to 3 doctors.
The most common payment nature for iStent infinite Trabecular Micro-Bypass System Model iS3 is "Unspecified" ($165,421, 50.2% of total).
iStent infinite Trabecular Micro-Bypass System Model iS3 is associated with 2 research studies, including "A Prospective, Randomized, Controlled, Comparative Multicenter Clinical Studyof Glaukos Trabecular Micro-Bypass System Model iS3 Infinite vs. Hydrus in Adult Subjects With Primary Open-Angle Glaucoma (POAG)" ($128,111).